New onset systemic lupus erythematosus in a patient receiving etanercept for rheumatoid arthritis
about
Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safetyAutoantibody profile in rheumatoid arthritis during long-term infliximab treatmentA comprehensive review and evaluation of the side effects of the tumor necrosis factor alpha blockers etanercept, infliximab and adalimumabCurrent evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitisAnaphylactic reaction to anakinra in a rheumatoid arthritis patient intolerant to multiple nonbiologic and biologic disease-modifying antirheumatic drugs.A randomized, pilot trial of etanercept in dermatomyositis.Etanercept-induced systemic lupus erythematosus.ASAS/EULAR recommendations for the management of ankylosing spondylitis.Discoid lupus erythematosus-like eruption induced by infliximab.The safety of etanercept for the treatment of plaque psoriasis.Anti-Tumor Necrosis Factor-α Induced Systemic Lupus Erythematosus().A role for transcription factor NF-kappaB in autoimmunity: possible interactions of genes, sex, and the immune response.Etanercept: long-term clinical experience in rheumatoid arthritis and other arthritis.Autoantibody production in anti-TNF-alpha-treated patients.Etanercept-induced systemic lupus erythematosus in a patient with rheumatoid arthritis.Systematic review of tumor necrosis factor inhibitor discontinuation studies in rheumatoid arthritis.Etanercept: efficacy and safety for approved indications.TNF-alpha antagonist induced lupus on three different agents.Accumulation of plasma nucleosomes upon treatment with anti-tumour necrosis factor-alpha antibodies.
P2860
Q24673716-9DD404BF-E419-4A08-A149-116239E9CE9FQ24800888-9560A254-C735-4BB5-B975-71B1E4D166F7Q28282330-BB7EEE59-00E7-43B1-BC8A-67B29179DA40Q33222422-15B61EE2-421D-4777-A08C-8D6FE2E977CAQ34124760-09A074F0-3A20-47D6-A88A-6F2DFCB8125FQ35206687-10FDC828-3838-453E-82E2-1372DBE47C51Q35583363-4314C131-D9C6-457F-9C0D-6301DA94FDB6Q35637012-D5376712-6C8D-44C4-866D-C5E602D61DC0Q35677025-5AAE0385-B612-43BD-9088-7832F0810ECCQ35919214-38A561A7-9C68-45E7-B215-B9EC20B1B796Q36418745-916F2E5C-C0AF-4DEB-810A-BE16929935ECQ36654727-7C9A3A54-095E-4459-83FA-2C05F5F646DBQ36847326-E3B42794-97E3-4ACE-992E-F8FB857322CFQ36958337-B8834873-0E4D-4431-A58B-3898717C5A77Q37292333-09E757BC-E2E4-45D5-804E-C1FB265B5112Q37567461-BD81F5EC-99EE-430E-B61E-C937350D51E8Q37954714-3F8CC7B9-B2B3-4609-8AB2-24399C0FDEDCQ47964826-591D451E-46EC-4ADE-A85A-D607D7228E48Q51052396-C1D97560-1A6D-4AC4-B74E-01D222CA557E
P2860
New onset systemic lupus erythematosus in a patient receiving etanercept for rheumatoid arthritis
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
New onset systemic lupus eryth ...... rcept for rheumatoid arthritis
@ast
New onset systemic lupus eryth ...... rcept for rheumatoid arthritis
@en
type
label
New onset systemic lupus eryth ...... rcept for rheumatoid arthritis
@ast
New onset systemic lupus eryth ...... rcept for rheumatoid arthritis
@en
prefLabel
New onset systemic lupus eryth ...... rcept for rheumatoid arthritis
@ast
New onset systemic lupus eryth ...... rcept for rheumatoid arthritis
@en
P2093
P356
P1476
New onset systemic lupus eryth ...... rcept for rheumatoid arthritis
@en
P2093
P304
P356
10.1136/ARD.61.11.1031
P407
P577
2002-11-01T00:00:00Z